Brooklyn Chest Hospital: A Decade of Hope and Innovation in Pediatric TB Treatment
Nestled in the industrial suburb of Paarden Island, Cape Town, Brooklyn Chest Hospital is a beacon of care and groundbreaking research for children battling tuberculosis (TB). With its bright, mural-adorned wards and dedicated staff, the hospital is celebrating ten years as a global leader in pediatric TB treatment and research.
The hospital, home to 300 beds, specializes in treating severe and complicated TB cases, including TB meningitis and multidrug-resistant TB. Currently, 31 children occupy its 40 pediatric beds, with stays ranging from two months to over three years, depending on the severity of their illness and family circumstances.
A Day in the Wards
The pediatric wards are alive with energy. Teacher Noxolo Mlata reads to children aged 3 to 6, who eagerly identify colors on the pages of her book. Nearby, nurse Goodness Ngubane tenderly feeds a young boy confined to a wheelchair while infants buzz around her excitedly. Staff move without masks, as none of the young patients pose an infection risk.
Sister Anastasia Cornelius, a long-time caregiver at the hospital, explains the diverse needs of the children. “We have a 13-year-old boy who is small for his age and has special needs,” she says. “He’s been here for over three years and is cured of TB meningitis, but his family can’t care for him. He’ll need a special home.”
Cornelius’s compassion shines as she scoops up a toddler in pink. “This one arrived two days ago. When her mum left yesterday, she cried, but now she’s doing well.” Another child plays with a unicorn soft toy, while Ngubane hugs a lively boy planting kisses on her cheek.
A Decade of Breakthroughs
Brooklyn Chest Hospital is also a clinical site for the Desmond Tutu TB Centre (DTTC), affiliated with Stellenbosch University. Over the past decade, DTTC’s research has transformed pediatric TB treatment, influencing World Health Organization (WHO) guidelines. Notable achievements include reducing treatment duration for non-severe TB in children from six to four months, easing the burden on families and healthcare systems.
The SHINE trial, a landmark study conducted across four countries, provided critical evidence for this change. DTTC led the South African arm of the study, involving 315 children in Cape Town, including some at Brooklyn Chest Hospital.
Dr. Susan Purchase, a research-clinician at DTTC, highlights the challenges of treating pediatric TB. “Many children here don’t have severe TB but lack caregivers who can administer their medication,” she explains. “Others suffer from TB meningitis, which can leave them disabled for life and in need of specialized care.”
Innovations in Diagnosis and Treatment
Diagnosing TB in children remains a significant challenge, as traditional sputum tests are difficult to administer. DTTC has explored alternatives like stool samples and tongue swabs, though neither is yet as reliable as sputum testing.
“You can’t ask a one-year-old to cough into a sputum bottle,” Purchase notes. “Instead, we use gastric aspirates, passing a tube into the stomach to collect swallowed phlegm.”
DTTC is also pioneering automated chest X-ray readings for children, leveraging AI to assist healthcare workers in resource-limited settings.
Resilience and Collaboration
Despite funding challenges, DTTC continues to thrive. Director Professor Anneke Hesseling highlights a groundbreaking collaboration with South Korea’s National Institute of Health, testing a promising new antibiotic, delpazolid, for multidrug-resistant TB.
“Delpazolid looks much safer than the current drug, linezolid, which causes severe side effects,” Hesseling says. “This partnership is exciting and a testament to our resilience.”
As Brooklyn Chest Hospital marks its tenth anniversary, it stands as a symbol of hope, innovation, and unwavering dedication to children battling TB.
— Reported by Nexio News
